- Home
- YHC vs TSBX Comparison
YHC vs TSBX Comparison
Compare YHC & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHC
- TSBX
- Stock Information
- Founded
- YHC 2021
- TSBX 2015
- Country
- YHC United States
- TSBX United States
- Employees
- YHC N/A
- TSBX N/A
- Industry
- YHC Beverages (Production/Distribution)
- TSBX
- Sector
- YHC Consumer Staples
- TSBX
- Exchange
- YHC Nasdaq
- TSBX Nasdaq
- Market Cap
- YHC 12.3M
- TSBX 11.4M
- IPO Year
- YHC N/A
- TSBX 2023
- Fundamental
- Price
- YHC N/A
- TSBX $0.48
- Analyst Decision
- YHC
- TSBX Buy
- Analyst Count
- YHC 0
- TSBX 3
- Target Price
- YHC N/A
- TSBX $4.75
- AVG Volume (30 Days)
- YHC 371.7K
- TSBX 93.1K
- Earning Date
- YHC 04-02-2025
- TSBX 11-12-2024
- Dividend Yield
- YHC N/A
- TSBX N/A
- EPS Growth
- YHC N/A
- TSBX N/A
- EPS
- YHC N/A
- TSBX N/A
- Revenue
- YHC $2,272,001.00
- TSBX N/A
- Revenue This Year
- YHC N/A
- TSBX N/A
- Revenue Next Year
- YHC N/A
- TSBX N/A
- P/E Ratio
- YHC N/A
- TSBX N/A
- Revenue Growth
- YHC 158.05
- TSBX N/A
- 52 Week Low
- YHC $0.40
- TSBX $0.40
- 52 Week High
- YHC $3.47
- TSBX $5.75
- Technical
- Relative Strength Index (RSI)
- YHC N/A
- TSBX 39.58
- Support Level
- YHC N/A
- TSBX $0.48
- Resistance Level
- YHC N/A
- TSBX $0.51
- Average True Range (ATR)
- YHC 0.00
- TSBX 0.05
- MACD
- YHC 0.00
- TSBX -0.00
- Stochastic Oscillator
- YHC 0.00
- TSBX 22.22
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.